- Morgan Stanley Global Healthcare Conference, New York City, September 9, 2013, 10:35 a.m. ET
- Stifel Healthcare Conference 2013, Boston, September 11, 2013, 9:45 a.m. ET
Insiders at Infinity Pharmaceuticals and Och-Ziff Capital Management Group -- among other companies -- have been scooping up shares of their own stock lately.
Infinity Pharmaceuticals (INFI) said preliminary results from its IPI-549 drug trial showed that the cancer treatment can reverse tumor resistance to checkpoint inhibitors.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.